Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2022

View Archived Issues

S2K146 protects against SARS-CoV-2 infection in preclinical models

Exon-skipping antisense oligonucleotides show promise for treating cystic fibrosis

TRAF6 loss linked to development of myeloid malignancies

Discovery of novel mGlu4 receptor PAMs with antipsychotic-like properties

Zealand Pharma divulges LPAM-1 antagonists

Array BioPharma discloses new HER2 inhibitors

Cadila Healthcare synthesizes ENPP2 inhibitors

CGeneTech identifies new CDK inhibitors

Chinese investigators describe AGTR2 antagonists

Repurposed drug promoting systemic arginine catabolism improves energy homeostasis in obese mice

Synergistic antitumor activity of rencofilstat + anti-PD-1 in mice with fatty livers and HCC

IL-2Rbeta agonist MDNA-11 shows promising results in preclinical cancer models

Somatic tissue engineering gives insights into ovarian cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...